Goldman Sachs upgraded Bruker (BRKR) to Neutral from Sell with an unchanged price target of $60. The firm believes Bruker’s market position has improved since its initiation with a Sell rating given the company’s focused investment in high growth areas, insulating it from slower overall market growth. Despite Bruker’s improved exposure, the shares are trading at the highest discount to peers in over 10 years, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: